Cancer Biomarker Market Report

China Cancer Biomarker Industry Market Research Report 2023-2029

  • POSTDATE：Aug 27, 2023
  • PAGES：170
  • REPORT CODE：GMM1760702
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Cancer Biomarker industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Genomic Health

    • BioCept

    • PGD

    • DiagnoCure

    • Atossa Genetics

    • Foundation Medicine

    • Biophysical

    • BioTheranostics

    • GenomeDx

    • Abbott

    • Gen-Probe

    • 20/20 GeneSystems

    • Nodality

    • Dako (Agilent)

    • Molecular Response

    • Cynvenio

    • Life Technologies

    By Type:

    • Companion diagnostic biomarkers

    • Screening, detection, risk assessment, and monitoring biomarkers

    • Prognosis and prediction biomarkers

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cancer Biomarker Market Overview 2018-2029

    • 1.1 China Cancer Biomarker Industry Development Overview

    • 1.2 China Cancer Biomarker Industry Development History

    • 1.3 China Cancer Biomarker Industry Market Size (2018-2029)

    • 1.4 China Cancer Biomarker Market Analysis by Type from Production Side

      • 1.4.1 China Cancer Biomarker Production Volume, Production Value and Growth Rate of Companion diagnostic biomarkers (2018-2029)

      • 1.4.2 China Cancer Biomarker Production Volume, Production Value and Growth Rate of Screening, detection, risk assessment, and monitoring biomarkers (2018-2029)

      • 1.4.3 China Cancer Biomarker Production Volume, Production Value and Growth Rate of Prognosis and prediction biomarkers (2018-2029)

    • 1.5 China Cancer Biomarker Market Analysis by Application from Consumption End

      • 1.5.1 China Cancer Biomarker Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Cancer Biomarker Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Cancer Biomarker Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Cancer Biomarker Market Analysis by Region

      • 1.6.1 North China Cancer Biomarker Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cancer Biomarker Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cancer Biomarker Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cancer Biomarker Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cancer Biomarker Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cancer Biomarker Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cancer Biomarker Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cancer Biomarker Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cancer Biomarker Market Status and Competition Analysis in 2023

      • 2.2.3 China Cancer Biomarker Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cancer Biomarker Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cancer Biomarker Industry Development

    Chapter 3 Cancer BiomarkerIndustry Chain Analysis

    • 3.1 Cancer Biomarker Industry Chain

    • 3.2 Cancer Biomarker Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cancer Biomarker Market

    • 3.3 Cancer Biomarker Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cancer Biomarker Market

    Chapter 4 China Cancer Biomarker Market, by Type

    • 4.1 China Cancer Biomarker Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cancer Biomarker Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cancer Biomarker Production Volume and Growth Rate, by Type

      • 4.5.1 China Cancer Biomarker Production Volume and Growth Rate of Companion diagnostic biomarkers

      • 4.5.2 China Cancer Biomarker Production Volume and Growth Rate of Screening, detection, risk assessment, and monitoring biomarkers

      • 4.5.3 China Cancer Biomarker Production Volume and Growth Rate of Prognosis and prediction biomarkers

    Chapter 5 China Cancer Biomarker Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cancer Biomarker Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cancer Biomarker Market Size and Growth Rate, by Application

      • 5.5.1 China Cancer Biomarker Market Size and Growth Rate of Application 1

      • 5.5.2 China Cancer Biomarker Market Size and Growth Rate of Application 2

      • 5.5.3 China Cancer Biomarker Market Size and Growth Rate of Application 3

    Chapter 6 China Cancer Biomarker Market, by Region

    • 6.1 China Cancer Biomarker Production Volume and Production Value, by Region

    • 6.2 China Cancer Biomarker Sales Volume and Sales Value, by Region

    Chapter 7 North China Cancer Biomarker Market Analysis

    • 7.1 North China Cancer Biomarker Market, by Type

    • 7.2 North China Cancer Biomarker Market, by Application

    Chapter 8 Central China Cancer Biomarker Market Analysis

    • 8.1 Central China Cancer Biomarker Market, by Type

    • 8.2 Central China Cancer Biomarker Market, by Application

    Chapter 9 South China Cancer Biomarker Market Analysis

    • 9.1 South China Cancer Biomarker Market, by Type

    • 9.2 South China Cancer Biomarker Market, by Application

    Chapter 10 East China Cancer Biomarker Market Analysis

    • 10.1 East China Cancer Biomarker Market, by Type

    • 10.2 East China Cancer Biomarker Market, by Application

    Chapter 11 Northeast China Cancer Biomarker Market Analysis

    • 11.1 Northeast China Cancer Biomarker Market, by Type

    • 11.2 Northeast China Cancer Biomarker Market, by Application

    Chapter 12 Southwest China Cancer Biomarker Market Analysis

    • 12.1 Southwest China Cancer Biomarker Market, by Type

    • 12.2 Southwest China Cancer Biomarker Market, by Application

    Chapter 13 Northwest China Cancer Biomarker Market Analysis

    • 13.1 Northwest China Cancer Biomarker Market, by Type

    • 13.2 Northwest China Cancer Biomarker Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Genomic Health

        • 14.1.1 Genomic Health Company Profile

        • 14.1.2 Genomic Health Cancer Biomarker Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BioCept

        • 14.2.1 BioCept Company Profile

        • 14.2.2 BioCept Cancer Biomarker Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 PGD

        • 14.3.1 PGD Company Profile

        • 14.3.2 PGD Cancer Biomarker Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 DiagnoCure

        • 14.4.1 DiagnoCure Company Profile

        • 14.4.2 DiagnoCure Cancer Biomarker Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Atossa Genetics

        • 14.5.1 Atossa Genetics Company Profile

        • 14.5.2 Atossa Genetics Cancer Biomarker Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Foundation Medicine

        • 14.6.1 Foundation Medicine Company Profile

        • 14.6.2 Foundation Medicine Cancer Biomarker Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Biophysical

        • 14.7.1 Biophysical Company Profile

        • 14.7.2 Biophysical Cancer Biomarker Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 BioTheranostics

        • 14.8.1 BioTheranostics Company Profile

        • 14.8.2 BioTheranostics Cancer Biomarker Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GenomeDx

        • 14.9.1 GenomeDx Company Profile

        • 14.9.2 GenomeDx Cancer Biomarker Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Abbott

        • 14.10.1 Abbott Company Profile

        • 14.10.2 Abbott Cancer Biomarker Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Gen-Probe

        • 14.11.1 Gen-Probe Company Profile

        • 14.11.2 Gen-Probe Cancer Biomarker Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 20/20 GeneSystems

        • 14.12.1 20/20 GeneSystems Company Profile

        • 14.12.2 20/20 GeneSystems Cancer Biomarker Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Nodality

        • 14.13.1 Nodality Company Profile

        • 14.13.2 Nodality Cancer Biomarker Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Dako (Agilent)

        • 14.14.1 Dako (Agilent) Company Profile

        • 14.14.2 Dako (Agilent) Cancer Biomarker Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Molecular Response

        • 14.15.1 Molecular Response Company Profile

        • 14.15.2 Molecular Response Cancer Biomarker Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Cynvenio

        • 14.16.1 Cynvenio Company Profile

        • 14.16.2 Cynvenio Cancer Biomarker Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Life Technologies

        • 14.17.1 Life Technologies Company Profile

        • 14.17.2 Life Technologies Cancer Biomarker Market Performance

        • 14.17.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cancer Biomarker Industry Research Conclusions

    • 15.2 Cancer Biomarker Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cancer Biomarker Industry Market Size (2018-2029)

    • Figure China Cancer Biomarker Production Volume, Production Value and Growth Rate of Companion diagnostic biomarkers (2018-2029)

    • Figure China Cancer Biomarker Production Volume, Production Value and Growth Rate of Screening, detection, risk assessment, and monitoring biomarkers (2018-2029)

    • Figure China Cancer Biomarker Production Volume, Production Value and Growth Rate of Prognosis and prediction biomarkers (2018-2029)

    • Figure China Cancer Biomarker Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Cancer Biomarker Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Cancer Biomarker Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure Central China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure South China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure East China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cancer Biomarker Market Size and Growth Rate from 2018-2029

    • Figure Cancer Biomarker Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cancer Biomarker Market Share by Type in 2018

    • Figure China Cancer Biomarker Market Share by Type in 2023

    • Figure China Cancer Biomarker Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cancer Biomarker Production Volume and Growth Rate of Companion diagnostic biomarkers (2018-2023)

    • Figure China Cancer Biomarker Production Volume and Growth Rate of Screening, detection, risk assessment, and monitoring biomarkers (2018-2023)

    • Figure China Cancer Biomarker Production Volume and Growth Rate of Prognosis and prediction biomarkers (2018-2023)

    • Figure China Cancer Biomarker Market Share by Application in 2018

    • Figure China Cancer Biomarker Market Share by Application in 2023

    • Figure China Cancer Biomarker Total Market Size and Growth Rate from Consumption End

    • Figure China Cancer Biomarker Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Cancer Biomarker Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Cancer Biomarker Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Cancer Biomarker Production Volume by Region (2018-2023)

    • Table China Cancer Biomarker Production Volume Share by Region (2018-2023)

    • Figure China Cancer Biomarker Production Volume Share by Region (2018-2023)

    • Table China Cancer Biomarker Production Value by Region (2018-2023)

    • Table China Cancer Biomarker Production Value Share by Region (2018-2023)

    • Figure China Cancer Biomarker Production Value Share by Region (2018-2023)

    • Table China Cancer Biomarker Sales Volume by Region (2018-2023)

    • Table China Cancer Biomarker Sales Volume Share by Region (2018-2023)

    • Figure China Cancer Biomarker Sales Volume Share by Region (2018-2023)

    • Table China Cancer Biomarker Sales Value by Region (2018-2023)

    • Table China Cancer Biomarker Sales Value Share by Region (2018-2023)

    • Figure China Cancer Biomarker Sales Value Share by Region (2018-2023)

    • Table North China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table North China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure North China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table North China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table North China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure North China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table Central China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table Central China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure Central China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table Central China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table Central China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure Central China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table South China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table South China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure South China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table South China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table South China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure South China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table East China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table East China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure East China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table East China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table East China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure East China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table Northeast China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table Northeast China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table Northeast China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table Southwest China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table Southwest China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table Southwest China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cancer Biomarker Production Volume by Type (2018-2023)

    • Table Northwest China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cancer Biomarker Production Volume Share by Type (2018-2023)

    • Table Northwest China Cancer Biomarker Sales Volume by Application (2018-2023)

    • Table Northwest China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cancer Biomarker Sales Volume Share by Application (2018-2023)

    • Table Genomic Health Company Profile

    • Table Genomic Health Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table BioCept Company Profile

    • Table BioCept Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table PGD Company Profile

    • Table PGD Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table DiagnoCure Company Profile

    • Table DiagnoCure Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Atossa Genetics Company Profile

    • Table Atossa Genetics Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Foundation Medicine Company Profile

    • Table Foundation Medicine Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Biophysical Company Profile

    • Table Biophysical Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table BioTheranostics Company Profile

    • Table BioTheranostics Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table GenomeDx Company Profile

    • Table GenomeDx Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Gen-Probe Company Profile

    • Table Gen-Probe Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table 20/20 GeneSystems Company Profile

    • Table 20/20 GeneSystems Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Nodality Company Profile

    • Table Nodality Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Dako (Agilent) Company Profile

    • Table Dako (Agilent) Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Molecular Response Company Profile

    • Table Molecular Response Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Cynvenio Company Profile

    • Table Cynvenio Cancer Biomarker Revenue, Price and Gross (2018-2023)

    • Table Life Technologies Company Profile

    • Table Life Technologies Cancer Biomarker Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US